The US Food and Drug Administration have announced their approval of a higher dose of naloxone hydrochloride nasal spray for the treatment of opioid overdose.
The US Food and Drug Administration (FDA) revoked the emergency use authorization (EUA) issued to the monoclonal antibody bamlanivimab, for the treatment of mild to moderate COVID-19.
The US Food and Drug Administration cleared a test that detects Chlamydia trachomatis and Neisseria gonorrhoeae in roughly 30 minutes, for use in point-of-care settings.
On February 27, 2021, the US Food and Drug Administration issued an emergency use authorization (EUA) for the Janssen COVID-19 vaccine. This is the third vaccine authorized by the FDA to prevent COVID-19.
...
The FDA has approved Humira (Adalimumab) for the treatment of moderately to severly active ulcerative colitis (UC) in pediatric patients aged 5 years or older.
The US Food and Drug Administration has issued an emergency use authorization for a new combination of monoclonal antibodies for treating patients with mild to moderate COVID-19 who are at risk of...
